Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Ip

Showing results (371-380 of 373) with videos related to

Pageof 38
Sort By:
You have reached the last page of results.This site can display upto 373 results.
The Lancet. Infectious Diseases|June 28, 2015
Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort studyTimothy M Walker, Thomas A Kohl, Shaheed V Omar, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Discovery of chromatin-based determinants of azacytidine and decitabine anti-cancer activityRishi V Puram, Qiangzong Yin, YuhJong Liu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 30, 2026
Targeted blood proteome profiling using NULISAseq identifies a high-performance biomarker panel for Aβ pathology quantification and stagingWenyue Zheng, Yuanbing Jiang, Hiu Yi Wong, et al.
Pageof 38

Showing results (371-380 of 373) with videos related to

Sort By:
Pageof 38
You have reached the last page of results.This site can display upto 373 results.
The Lancet. Infectious Diseases|June 28, 2015
Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort studyTimothy M Walker, Thomas A Kohl, Shaheed V Omar, et al.
Biorxiv : the Preprint Server for Biology|August 6, 2025
Discovery of chromatin-based determinants of azacytidine and decitabine anti-cancer activityRishi V Puram, Qiangzong Yin, YuhJong Liu, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 30, 2026
Targeted blood proteome profiling using NULISAseq identifies a high-performance biomarker panel for Aβ pathology quantification and stagingWenyue Zheng, Yuanbing Jiang, Hiu Yi Wong, et al.
Pageof 38